Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.
AffiliationDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom
MetadataShow full item record
AbstractThere is little evidence to guide treatment in elderly patients with muscle invasive bladder cancer (MIBC). We evaluated the efficacy and tolerability of concurrent radical radiotherapy with gemcitabine radiosensitisation (GemX) in elderly patients with MIBC and compared outcomes to those from the bladder carbogen and nicotinamide (BCON) phase III trial.
CitationOutcomes of radiosensitisation in elderly patients with advanced bladder cancer. 2018, Radiother Oncol
JournalRadiotherapy and Oncology